{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T14:27:45Z","timestamp":1795271265623,"version":"4.10.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V020935\/1"],"award-info":[{"award-number":["MR\/V020935\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V020935\/1"],"award-info":[{"award-number":["MR\/V020935\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V020935\/1"],"award-info":[{"award-number":["MR\/V020935\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V020935\/1"],"award-info":[{"award-number":["MR\/V020935\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V020935\/1"],"award-info":[{"award-number":["MR\/V020935\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The increased availability of large-scale longitudinal data offers important opportunities to assess the causal effects of health interventions. In this setting, Instrumental Variable (IV) approaches have the potential to reduce the risk of bias from confounding due to unmeasured variables. However, there has been a lack of attention given to the development of IV approaches in settings when both the instrument and the potential confounders vary over time. In this paper we critically evaluate two instrumental variable approaches in time-varying settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The paper extends an existing g-estimation method that incorporates time-fixed IVs and compares it to an inverse probability weighting approach that incorporates time-varying IVs. A simulation study investigates the relative performance of these two approaches under varying scenarios. These methods are applied to a retrospective cohort from the US National Databank for Rheumatic Diseases, evaluating the sustained use of Adalimumab (Humira) versus other biologics on the health-related quality of life of patients with Rheumatoid Arthritis. Our case study considers physicians preference for Adalimumab as an instrument.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The g-estimation approach provided unbiased, precise estimates of treatment effects, across a wide range of scenarios, including weak IVs and complex time-varying confounding mechanisms. The performance of the weighting approach was reasonable in scenarios with a moderate or strong time-varying IV, but deteriorated with weak IV strength. Both methods suggest that sustained treatment with Adalimumab does not improve the health-related quality of life of rheumatoid patients, compared to other biologics, but the g-estimation approach led to narrower confidence intervals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The proposed IV-based g-estimation approach can be reliably used in the estimation of time-varying treatments if a valid time-varying IV is available. The weighting approach offers an accessible alternative but was found to work well only when the IVs are strongly associated with treatment assignment, which is relatively unlikely in real-world applications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12874-025-02625-y","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:30:36Z","timestamp":1756794636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Instrumental variable approaches for estimating time-varying treatment effects in comparative effectiveness research"],"prefix":"10.1186","volume":"25","author":[{"given":"Daniel","family":"Tompsett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Vansteelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Grieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"2625_CR1","doi-asserted-by":"publisher","unstructured":"Daniel R, Cousens S, De\u00a0Stavola B, Kenward M, Sterne J. Methods for dealing with time-dependent confounding. Stat Med. 2013;32. https:\/\/doi.org\/10.1002\/sim.5686.","DOI":"10.1002\/sim.5686"},{"key":"2625_CR2","volume-title":"Causal Inference: What If","author":"M Hern\u00e1n","year":"2020","unstructured":"Hern\u00e1n M, Robins J. Causal inference: what if. Boca Raton: Chapman and Hall\/CRC; 2020."},{"key":"2625_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.ede.0000222409.00878.37","volume":"17","author":"M Hern\u00e1n","year":"2006","unstructured":"Hern\u00e1n M, Robins J. Instruments for causal inference: an epidemiologist\u2019s dream? Epidemiology (Cambridge, Mass). 2006;17:360\u201372. https:\/\/doi.org\/10.1097\/01.ede.0000222409.00878.37.","journal-title":"Epidemiology (Cambridge, Mass)."},{"key":"2625_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1191\/0962280205sm407oa","volume":"14","author":"E Goetghebeur","year":"2005","unstructured":"Goetghebeur E, Vansteelandt S. Structural mean models for compliance analysis in randomized clinical trials and the impact of errors on measures of exposure. Stat Methods Med Res. 2005;14:397\u2013415. https:\/\/doi.org\/10.1191\/0962280205sm407oa.","journal-title":"Stat Methods Med Res."},{"key":"2625_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"J Robins","year":"2000","unstructured":"Robins J, Hern\u00e1n M, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550\u201360. https:\/\/doi.org\/10.1097\/00001648-200009000-00011.","journal-title":"Epidemiology."},{"key":"2625_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/EDE.0000000000001417","volume":"33","author":"J Shi","year":"2022","unstructured":"Shi J, Swanson S, Kraft P, Rosner B, Vivo I, Hern\u00e1n M. Mendelian Randomization With Repeated Measures of a Time-varying Exposure: An Application of Structural Mean Models. Epidemiology. 2022;33:84\u201394. https:\/\/doi.org\/10.1097\/EDE.0000000000001417.","journal-title":"Epidemiology."},{"key":"2625_CR7","doi-asserted-by":"publisher","unstructured":"Hogan J. Longitudinal data analysis edited by G. Fitzmaurice, M. Davidian, G. Verbeke, and G. Molenberghs. Biometrics. 2010;66. https:\/\/doi.org\/10.1111\/j.1541-0420.2010.01478.x.","DOI":"10.1111\/j.1541-0420.2010.01478.x"},{"key":"2625_CR8","doi-asserted-by":"publisher","unstructured":"Giraitis L, Kapetanios G, Marcellino M. Time-varying instrumental variable estimation. J Econ. 2020;224. https:\/\/doi.org\/10.1016\/j.jeconom.2020.08.013.","DOI":"10.1016\/j.jeconom.2020.08.013"},{"key":"2625_CR9","doi-asserted-by":"publisher","unstructured":"Burgess S, Thompson S. Re: \u201cMultivariable mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects\u201d. Am J Epidemiol. 2015;181. https:\/\/doi.org\/10.1093\/aje\/kwu283.","DOI":"10.1093\/aje\/kwu283"},{"key":"2625_CR10","doi-asserted-by":"publisher","unstructured":"Sanderson E, Smith G, Windmeijer F, Bowden J. An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings. Int J Epidemiol. 2020;49. https:\/\/doi.org\/10.1093\/ije\/dyaa101.","DOI":"10.1093\/ije\/dyaa101"},{"key":"2625_CR11","doi-asserted-by":"publisher","first-page":"11480","DOI":"10.1609\/aaai.v38i10.29029","volume":"38","author":"D Cheng","year":"2024","unstructured":"Cheng D, Xu Z, Li J, Liu L, Liu J, Gao W, et al. Instrumental Variable Estimation for Causal Inference in Longitudinal Data with Time-Dependent Latent Confounders. Proc AAAI Conf Artif Intell. 2024;38:11480\u20138. https:\/\/doi.org\/10.1609\/aaai.v38i10.29029.","journal-title":"Proc AAAI Conf Artif Intell."},{"key":"2625_CR12","unstructured":"Bica I, Alaa AM, van\u00a0der Schaar M. Time series deconfounder: estimating treatment effects over time in the presence of hidden confounders. 2020.\u00a0https:\/\/arxiv.org\/abs\/1902.00450. Accessed 24 Feb 2024."},{"key":"2625_CR13","unstructured":"Melnychuk V, Frauen D, Feuerriegel S. Causal transformer for estimating counterfactual outcomes. 2022. https:\/\/arxiv.org\/abs\/2204.07258.\u00a0Accessed 24 Feb 2025."},{"key":"2625_CR14","doi-asserted-by":"publisher","unstructured":"Michael H, Cui Y, Lorch S, Tchetgen E. Instrumental variable estimation of marginal structural mean models for time-varying treatment. J Am Stat Assoc. 2023;1\u201323. https:\/\/doi.org\/10.1080\/01621459.2023.2183131.","DOI":"10.1080\/01621459.2023.2183131"},{"key":"2625_CR15","doi-asserted-by":"publisher","unstructured":"Cui Y, Michael H, Tanser F, Tchetgen E. Instrumental variable estimation of the marginal structural Cox model for time-varying treatments. Biometrika. 2021;110. https:\/\/doi.org\/10.1093\/biomet\/asab062.","DOI":"10.1093\/biomet\/asab062"},{"issue":"1","key":"2625_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/tcrm.2007.3.1.133","volume":"3","author":"PJ Mease","year":"2007","unstructured":"Mease PJ. Adalimumab in the treatment of arthritis. Ther Clin Risk Manag. 2007;3(1):133\u201348.","journal-title":"Ther Clin Risk Manag."},{"key":"2625_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20350","volume":"20","author":"M Stevenson","year":"2016","unstructured":"Stevenson M, Archer R, Tosh J, Simpson E, Hock E, Stevens J, et al. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: Systematic review and economic evaluation. Health Technol Assess (Winchester, England). 2016;20:1\u2013610. https:\/\/doi.org\/10.3310\/hta20350.","journal-title":"Health Technol Assess (Winchester, England)."},{"key":"2625_CR18","first-page":"100","volume":"34","author":"K Michaud","year":"2016","unstructured":"Michaud K. The National Data Bank for Rheumatic Diseases. Clin Exp Rheumatol. 2016;34:100\u20131.","journal-title":"Clin Exp Rheumatol."},{"key":"2625_CR19","doi-asserted-by":"publisher","unstructured":"Widding-Havneraas T, Chaulagain A, Lyhmann I, Zachrisson H, Elwert F, Markussen S, et\u00a0al. Preference-based instrumental variables in health research rely on important and underreported assumptions: a systematic review. J Clin Epidemiol. 2021;139. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.06.006.","DOI":"10.1016\/j.jclinepi.2021.06.006"},{"key":"2625_CR20","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.jclinepi.2008.12.006","volume":"62","author":"J Rassen","year":"2009","unstructured":"Rassen J, Brookhart M, Glynn R, Mittleman M, Schneeweiss S. Instrumental Variables II: Instrumental Variable Application In 25 Variations, the Physician Prescribing Preference Generally was Strong and Reduced Covariate Imbalance. J Clin Epidemiol. 2009;62:1233\u201341. https:\/\/doi.org\/10.1016\/j.jclinepi.2008.12.006.","journal-title":"J Clin Epidemiol."},{"key":"2625_CR21","doi-asserted-by":"publisher","unstructured":"Brookhart M, Schneeweiss S. Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat. 2007;3:Article 14. https:\/\/doi.org\/10.2202\/1557-4679.1072.","DOI":"10.2202\/1557-4679.1072"},{"key":"2625_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson S. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364. https:\/\/doi.org\/10.1093\/ije\/dyr036.","journal-title":"Int J Epidemiol."},{"key":"2625_CR23","doi-asserted-by":"publisher","unstructured":"Stock J, Yogo M. Testing for weak instruments in linear IV regression. SSRN eLibrary. 2002;11. https:\/\/doi.org\/10.1017\/CBO9780511614491.006.","DOI":"10.1017\/CBO9780511614491.006"},{"key":"2625_CR24","doi-asserted-by":"publisher","unstructured":"Wang L, Tchetgen E. Bounded, efficient and multiply robust estimation of average treatment effects using instrumental variables. J R Stat Soc Ser B (Stat Methodol). 2016;80. https:\/\/doi.org\/10.1111\/rssb.12262.","DOI":"10.1111\/rssb.12262"},{"key":"2625_CR25","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna; 2019. https:\/\/www.R-project.org\/.\u00a0Accessed 24 Feb 2025."},{"key":"2625_CR26","doi-asserted-by":"publisher","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences(2nd ed.). United Kingdom: Routledge; 1988. https:\/\/doi.org\/10.4324\/9780203771587.","DOI":"10.4324\/9780203771587"},{"issue":"11","key":"2625_CR27","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/sim.8086","volume":"38","author":"TP Morris","year":"2019","unstructured":"Morris TP, White IR, Crowther MJ. Using simulation studies to evaluate statistical methods. Stat Med. 2019;38(11):2074\u2013102.","journal-title":"Stat Med."},{"key":"2625_CR28","doi-asserted-by":"crossref","unstructured":"Moler\u00a0Zapata S, Grieve R, Basu A, O\u2019Neill S. How does a local instrumental variable method perform across settings with instruments of differing strengths? A simulation study and an evaluation of emergency surgery. Health Econ. 2023;32(9):2113\u20132126.","DOI":"10.1002\/hec.4719"},{"key":"2625_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/em-2012-0006","volume":"2","author":"Y Xiao","year":"2013","unstructured":"Xiao Y, Moodie E, Abrahamowicz M. Comparison of Approaches to Weight Truncation for Marginal Structural Cox Models. Epidemiol Methods. 2013;2:1\u201320. https:\/\/doi.org\/10.1515\/em-2012-0006.","journal-title":"Epidemiol Methods."},{"key":"2625_CR30","doi-asserted-by":"publisher","unstructured":"Sturmer T, Webster-Clark M, Lund J, Wyss R, Ellis A, Lunt M, et\u00a0al. Propensity score weighting and trimming strategies to reduce variance and bias of treatment effect estimates: a simulation study. Am J Epidemiol. 2021;190. https:\/\/doi.org\/10.1093\/aje\/kwab041.","DOI":"10.1093\/aje\/kwab041"},{"key":"2625_CR31","doi-asserted-by":"crossref","unstructured":"Tian H, Burgess S. Estimation of time-varying causal effects with multivariable Mendelian randomization some cautionary notes. Int J Epidemiol. 2023;52:846\u2013857.","DOI":"10.1093\/ije\/dyac240"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-025-02625-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:15:54Z","timestamp":1757477754000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-025-02625-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2625"],"URL":"https:\/\/doi.org\/10.1186\/s12874-025-02625-y","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}